Navigation Links
Monsanto Executives to Discuss Company's Growth Drivers, Profit Goals at Investor Conferences in February
Date:2/4/2009

ST. LOUIS, Feb. 4 /PRNewswire-FirstCall/ -- On the heels of a strong start to fiscal 2009, Monsanto Company (NYSE: MON) executives will explain to investors this month where the company sees its opportunities for continued growth through the rest of this year and how it plans to achieve its goal of more than doubling its fiscal 2007 gross profit level by fiscal 2012.

Terry Crews, chief financial officer, and Carl Casale, executive vice president of strategy and operations, will address investors in separate presentations at two conferences later this month. Both Monsanto executives will provide an update on the company's business performance and expectations, strategic initiatives, product performance, research-and-development pipeline, and other business matters at these conferences:

Tuesday, February 10, 2009 - Terry Crews will be presenting at the Goldman Sachs 13th Annual Agricultural Biotech Forum in New York. Crews' presentation will begin at 2:30 p.m. eastern time.

Wednesday, February 18, 2009 - Carl Casale will be presenting at the 2009 Morgan Stanley Global Basic Materials Conference, also in New York. Casale's presentation will begin at 12:15 p.m. eastern time.

Presentation slides and simultaneous audio webcasts of the conference calls may be accessed by visiting the company's web site at http://www.monsanto.com/investors. Following the live broadcasts, Monsanto will archive the presentation slides and replays of the webcasts at the company's web site.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com.

Contact: Justin Gioia (314-694-4003)


'/>"/>
SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Monsanto Company Signs Share Subscription Agreement With Devgen
3. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
4. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
5. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Monsanto and Devgen Describe New Approach to Insect-Protection
9. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
10. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
11. Monsanto Executives to Address Investor Conferences in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... ... development, skill-building and compliance training platform on mobile devices, today released a new ... Regulatory Requirements for Medical Devices. The course is essential for owners or operators ...
(Date:5/3/2016)... ... May 03, 2016 , ... Flagship ... Dr. Nancy Gillett to its Board of Directors. Dr. Gillett recently retired from ... Executive Vice President and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. Gillett ...
(Date:5/3/2016)... , May 3, 2016 - ... Developers and Producers of Those Competitor Biologics  ... Companies, Activities and Prospects ,  Who are ... companies? And what are their sales potentials? Discover, in ... see results, trends, opportunities and revenue forecasting. ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... fertility clinics and IVF laboratories. A contingency of reproductive endocrinologists, including Dr. ... and women experiencing infertility and to help them build families. , Ovation Fertility ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):